Biotechnology Stock on the Move: Lexicon Pharmaceuticals Inc. (LXRX)
News | 27 June 2012
Shares of Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) surged in Tuesday's trading session. LXRX shares ended the day 15.64% higher at $2.26, extending their gains in the last three trading sessions to 19.31%. The stock touched a new 52-week high of ...
Click on the link to read the full article at Tech24
(This link will open in a new window)
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
